DiscoverBioTech WeeklyWeek 28 - Jul 7-13, 2025
Week 28 - Jul 7-13, 2025

Week 28 - Jul 7-13, 2025

Update: 2025-07-14
Share

Description

πŸ“’ Industry Highlights in Biotech & Life Sciences πŸ“’Β 

From leadership changes to licensing deals and product launches, here's a roundup of recent developments shaping the future of healthcare innovation:

Sources

πŸ”— Biocytogen Enters into Antibody Licensing Agreement with BeOne Medicines to Accelerate Innovative Drug Development

πŸ”— Radiant Biotherapeutics Appoints Deborah Geraghty, Ph.D., as President and Chief Executive Officer

πŸ”— enGene Announces Board and Leadership Appointments to Support Commercial Readiness

πŸ”— OTC Markets Group Welcomes Vaxart, Inc. to OTCQX

πŸ”— UAE Approves BioAro’s Longevity+ Supplement, Signaling Major Market Potential in Global Preventive Health

πŸ”— Invivoscribe Expands Flow Cytometry Services to Accelerate CAR-T Immunotherapy Development and Regulatory Readiness

πŸ”— ImmunoPrecise Antibodies Appoints Industry Veteran Jon Lieber to Board of Directors

πŸ”— Life Sciences BC Announces 2025 Awards Winners, Honouring Excellence in Health Innovation

πŸ”— Newly Elected Directors of Sinovac Hold the First Board Meeting

#biotech #lifesciences #healthcareinnovation #leadership #drugdevelopment #clinicaltrials #biopharma #LinkedInNews

πŸ’‘ Follow the BioTech Weekly newsletter for more updates on biotech breakthroughs, regulatory milestones, and investment trends in life sciences.

Disclaimer: This podcast includes content generated with the help of large language models (LLM). Although care has been taken to ensure accuracy, LLMs can sometimes produce incorrect or misleading information. Listeners are advised to independently verify any details, provide feedback, and reach out.

CommentsΒ 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Week 28 - Jul 7-13, 2025

Week 28 - Jul 7-13, 2025

Ernst Oberortner